Tiwari AK, Sodani K, DaiCL, Abuznait AH, Singh S, Xiao ZJ, Vispute S, Patel P, Talele TT, Fu LW,Kaddoumi A, Gallo JM, Chen ZS. Nilotinibpotentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrugresistance xenograft models. CancerLett. 2012 Oct 9. [Epub ahead of print] PMID: 23063650
Chen ZS and TiwariAK. Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy andhuman genetic diseases. FEBS J. 2011 Sep;278(18):3226-45. Epub2011 Aug 1. PMID: 21740521
Tiwari AK, Yang DH, and ChenZS. Molecular mechanisms of methotrexateresistance. Nova Science Publishers, Inc. ISBN – 978-1-62100-596-4, 2012
Shi Z, TiwariAK, Shukla S, Robey RW, Singh S, Kim IW, Bates SE, Peng XX, Abraham I,Ambudkar SV, Talele TT, Fu LW, Chen ZS. Sildenafil reverses ABCB1-and ABCG2-mediated chemotherapeutic drug resistance. Cancer Res, 2011 Apr 15;71(8):3029-41. Epub 2011 Mar 14. PMID: 21402712
Tiwari AK, Sodani K, Dai CL, Ashby C, Chen ZS. Revisitingthe ABCs of Multidrug Resistance in Cancer Chemotherapy. Curr Pharm Biotechnol. 2011 Apr 1;12(4):570-94. PMID: 21118094
Tiwari AK, Sodani K, Wang SR, Kuang YH, Ashby CR, Jr., Chen Xand Chen ZS. Nilotinib (AMN107, Tasigna) reverses multidrug resistance byinhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters. Biochem Pharmacol 2009 Jul 15;78(2):153-61. Epub 2009 Apr 11. PMID: 19427995
Tiwari AK, Xin A, Chen ZS. Therole of stem cell markers in multidrug resistance mediated by ABC transporters.Leukemia Res 34,696–697, 2010 doi:10.1016/j.leukres.2009.12.007. PMID:20061021
Dai CL, Tiwari AK*, Wu CP, Su XD, Wang SR, Liu DG, Ashby CR, Jr.,Huang Y, Robey RW, Liang YJ, Chen LM, Shi CJ, Ambudkar SV, Chen ZS and Fu LW.Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells byinhibiting the activity of ATP- binding cassette subfamily B member 1 and Gmember 2. Cancer Res 2008 Oct 1;68(19):7905- 14 (*Co-FirstAuthor). PMID: 18829547